A Study Of MCG In Cardiac Amyloidosis

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07218705
Status
Recruiting
Apply to this trial

Conditions

  • Amyloidosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SandboxAQ CardiAQ Magnetocardiography — DEVICE
    Magnetocardiography is a non-invasive, radiation-free imaging technique that detects the magnetic field generated by the electrical activity of the heart.

Study Details

The primary objective of this observational study is to evaluate the utility of magnetocardiography (MCG) in diagnosing and monitoring disease progression in patients with amyloidosis, and to assess its effectiveness in comparison to other modalities, such as ECG.

Key Dates

Start date
Dec 3, 2025
Status verified
Dec 2025
Primary completion
Nov 30, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Patients with amyloidosis

Primary Outcome Measure

Receiver Operating Characteristic (ROC) curve [ Time Frame: Baseline, 6 Months, 12 Months, 18 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Structural Heart Research Team
[email protected]
(507) 255-6133
Mohamad Adnan Alkhouli, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies